Literature DB >> 35316453

The role of lncRNA OIP5-AS1 in cancer development and progression.

Cheng Zheng1, Man Chu2, Qiuli Chen3,4, Cheng Chen2, Zhi-Wei Wang5, Xiao Chen6,7.   

Abstract

OIP5-AS1, a conserved lncRNA, has been reported to be involved in several biological and pathological processes, including oncogenesis. OIP5-AS1 exerts its oncogenic or antitumor functions via regulation of different miRNAs in various cancer types. In this review, we describe the dysregulation of OIP5-AS1 expression in a variety of human cancers. Moreover, we discuss the multiple functions of OIP5-AS1 in cancer, including in proliferation, apoptosis, autophagy, ferroptosis, cell cycle, migration, metastasis, invasion, epithelial to mesenchymal transition, angiogenesis, cancer stem cells and drug resistance. Furthermore, we provide a future perspective for OIP5-AS1 research. We conclude that targeting OIP5-AS1 might be a promising cancer therapy approach.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; OIP5-AS1; Oncogene; Therapy; miRNAs

Mesh：

Substances：

Year:  2022        PMID： 35316453     DOI： 10.1007/s10495-022-01722-3

Source DB:  PubMed          Journal:  Apoptosis        ISSN： 1360-8185            Impact factor:   4.677


  72 in total

Review 1.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

2.  LncRNA OIP5-AS1 reduces α-synuclein aggregation and toxicity by targeting miR-126 to activate PLK2 in human neuroblastoma SH-SY5Y cells.

Authors:  Zhiwei Song; Baoming Xie
Journal:  Neurosci Lett       Date:  2020-11-05       Impact factor: 3.046

3.  Up-regulating lncRNA OIP5-AS1 protects neuron injury against cerebral hypoxia-ischemia induced inflammation and oxidative stress in microglia/macrophage through activating CTRP3 via sponging miR-186-5p.

Authors:  Yuqin Chen; Weihua Liu; Mingyu Chen; Qingyun Sun; Hongyu Chen; Yufen Li
Journal:  Int Immunopharmacol       Date:  2021-01-27       Impact factor: 4.932

Review 4.  A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies.

Authors:  Soudeh Ghafouri-Fard; Sepideh Dashti; Molood Farsi; Bashdar Mahmud Hussen; Mohammad Taheri
Journal:  Biomed Pharmacother       Date:  2021-02-15       Impact factor: 6.529

5.  Long Noncoding RNA OIP5-AS1 Contributes to the Progression of Atherosclerosis by Targeting miR-26a-5p Through the AKT/NF-κB Pathway.

Authors:  Mingming Ren; Tao Wang; Zhen Han; Pengcheng Fu; Zigang Liu; Chun Ouyang
Journal:  J Cardiovasc Pharmacol       Date:  2020-11       Impact factor: 3.105

6.  Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2.

Authors:  Jun Deng; Huan Deng; Chunfeng Liu; Yujia Liang; Songping Wang
Journal:  Biomed Pharmacother       Date:  2017-12-14       Impact factor: 6.529

7.  Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers.

Authors:  Xiaolei Ren; Jieyu He; Lin Qi; Shuangqing Li; Chenghao Zhang; Zhixi Duan; Wanchun Wang; Chao Tu; Zhihong Li
Journal:  Artif Cells Nanomed Biotechnol       Date:  2020-12       Impact factor: 5.678

Review 8.  Long noncoding RNAs in cancer metastasis.

Authors:  S John Liu; Ha X Dang; Daniel A Lim; Felix Y Feng; Christopher A Maher
Journal:  Nat Rev Cancer       Date:  2021-05-05       Impact factor: 60.716

9.  MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma.

Authors:  Kai Xu; Sizhen Li; Qingsong Yang; Zixiu Zhou; Min Fu; Xiaodong Yang; Kuanxiao Hao; Yating Liu; Heqing Ji
Journal:  J Gene Med       Date:  2021-08-10       Impact factor: 4.565

Review 10.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694
View more
  3 in total

1.  LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma.

Authors:  Shuo Li; Mingxing Tang; Nan Zen; Junyi Liang; Xiao Xing; Danglin Huang; Fei Liu; Xiaomeng Zhang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

Review 2.  The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.

Authors:  Lu Xia; Jingyun Chen; Min Huang; Jie Mei; Min Lin
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

3.  LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion.

Authors:  Rong Li; Zhen Chen; Yubo Zhou; Gulikezi Maimaitirexiati; Qi Yan; Yuting Li; Adilijiang Maimaitiyimin; Changhui Zhou; Jingqin Ren; Chengqing Liu; Abasi Mainike; Peng Zhou; Lu Ding
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.